to equity holder of the company (10,892) 6,054 -280% (26,632) -59% (9,428) 16% Margin -2% 1% -5% -2% 2 (Unit : Thousand Baht) Separate F/S Q3/2019 Q3/2018 Δ% Q2/2019 Δ% Q1/2019 Δ% Revenues from sales
Medical Business Plc., (CMR) amount Baht 1,010.31 million. comparing at the same period in 2017 representing 18.19% increase. Income from medical treatments in the separate financial went up 17.07% due to
Chiang Mai Ram Medical Business Plc., (CMR) amount Baht 995.22 million comparing at the same period in 2018 representing 1.86% increase . Income from medical treatments in the separate financial went up
Derivatives Act B.E. 2546 (2003). - The SEC filed a criminal complaint against the alleged offender together with the others. The inquiry official informed the SEC to refile a separate criminal complaint
Act B.E. 2546 (2003). - The SEC filed a criminal complaint against the alleged offender together with the others. The inquiry official informed the SEC to refile a separate criminal complaint against
). - The SEC filed a criminal complaint against the alleged offender together with the others. The inquiry official informed the SEC to refile a separate criminal complaint against each alleged offender and
Derivatives Act B.E. 2546 (2003). - The SEC filed a criminal complaint against the alleged offender together with the others. The inquiry official informed the SEC to refile a separate criminal complaint
SEC filed a criminal complaint against the alleged offender together with the others. The inquiry official informed the SEC to refile a separate criminal complaint against each alleged offender and its
. 2546 (2003). - The SEC filed a criminal complaint against the alleged offender together with the others. The inquiry official informed the SEC to refile a separate criminal complaint against each alleged
SEC filed a criminal complaint against the alleged offender together with the others. The inquiry official informed the SEC to refile a separate criminal complaint against each alleged offender and its